BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29994987)

  • 1. Validation of an Isavuconazole High-Performance Liquid Chromatography Assay in Plasma for Routine Therapeutic Drug Monitoring Applications.
    Mueller SC; Karasch I; Lakner J; Wacke R
    Ther Drug Monit; 2018 Aug; 40(4):503-506. PubMed ID: 29994987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Müller C; Gehlen D; Blaich C; Prozeller D; Liss B; Streichert T; Wiesen MHJ
    Ther Drug Monit; 2017 Oct; 39(5):505-513. PubMed ID: 28742650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma.
    Nannetti G; Pagni S; Palù G; Loregian A
    Biomed Chromatogr; 2018 Nov; 32(11):e4333. PubMed ID: 29978912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples.
    Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A
    J Pharm Biomed Anal; 2017 Oct; 145():718-724. PubMed ID: 28806568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples.
    Toussaint B; Lanternier F; Woloch C; Fournier D; Launay M; Billaud E; Dannaoui E; Lortholary O; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():26-33. PubMed ID: 28131025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Chromatographic Ultraviolet Method for the Quantification of Isavuconazole in Human Plasma Samples.
    Cozzi V; Baldelli S; Castoldi S; Clementi E; Cattaneo D
    Ther Drug Monit; 2018 Aug; 40(4):512-514. PubMed ID: 29750740
    [No Abstract]   [Full Text] [Related]  

  • 7. Implementation of Isavuconazole in a Fluorescence-Based High-Performance Liquid Chromatography Kit Allowing Simultaneous Detection of All Four Currently Licensed Mold-Active Triazoles.
    Jørgensen R; Andersen SR; Astvad KMT; Arendrup MC
    mSphere; 2017; 2(3):. PubMed ID: 28497121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Smith A; Dowis J; French D
    Curr Protoc Toxicol; 2018 May; 76(1):e47. PubMed ID: 30040225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxy-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection.
    Wissen CP; Burger DM; Verweij PE; Aarnoutse RE; Brüggemann RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():79-84. PubMed ID: 22336695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole: Case Report and Pharmacokinetic Considerations.
    Marchesi F; Girmenia C; Goffredo BM; Salvatorelli E; Romano A; Mengarelli A; Minotti G; Menna P
    Chemotherapy; 2018; 63(5):253-256. PubMed ID: 30458443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
    Buckner SL; Ceesay MM; Pagliuca A; Morgan PE; Flanagan RJ
    Ther Drug Monit; 2011 Dec; 33(6):735-41. PubMed ID: 22105591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a Reversed-Phase Ultra-High-Performance Liquid Chromatographic Method With Photodiode Array Detection for the Determination of Voriconazole in Human Serum and Its Application to Therapeutic Drug Monitoring.
    Bressán IG; Mendez ML; Gimenez MI
    Ther Drug Monit; 2018 Apr; 40(2):276-283. PubMed ID: 29432386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
    Baietto L; D'Avolio A; Marra C; Simiele M; Cusato J; Pace S; Ariaudo A; De Rosa FG; Di Perri G
    J Antimicrob Chemother; 2012 Nov; 67(11):2645-9. PubMed ID: 22872447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Sustained Low-Efficiency Dialysis Treatment on Isavuconazole Plasma Levels in Critically Ill Patients.
    Lahmer T; Batres Baires G; Heilmaier M; Schmid RM; Sörgel F; Kinzig M; Huber W; Mayr U; Rasch S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
    Andes D; Kovanda L; Desai A; Kitt T; Zhao M; Walsh TJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
    Zhang M; Moore GA; Barclay ML; Begg EJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):484-9. PubMed ID: 23147736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.
    Chhun S; Rey E; Tran A; Lortholary O; Pons G; Jullien V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):223-8. PubMed ID: 17306633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases.
    Müller C; Arndt M; Queckenberg C; Cornely OA; Theisohn M
    Mycoses; 2006; 49 Suppl 1():17-22. PubMed ID: 16961577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the Triazole Antifungal Compounds Voriconazole and Posaconazole in Human Serum or Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
    Molinelli AR; Rose CH
    Methods Mol Biol; 2016; 1383():39-47. PubMed ID: 26660172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.